| Page 2026 | Kisaco Research
 

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India
 

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany
 
Health, Wellness & Money
21 Nov 2017
London, UK
Health, Wellness & Money is THE destination for the hottest early to mid-stage OTC health and wellness companies and healthtech innovators to connect with Strategic and Financial Buyers looking to build even more enterprise value with their next acquisition or investment.Every attendee, via the MEETING MOJO platform, will be able to schedule 12+ One-to-One private meetings to ensure the right connections are made.Why Consumer Health & Wellness? $3.4 TRILLION GLOBAL WELLNESS MARKET IS NOW THREE TIMES LARGER THAN WORLDWIDE PHARMACEUTICAL INDUSTRY. Global Wellness Institute StudyWellness sectors seeing the most significant growth since 2010 are:Healthy eating, nutrition and weight loss (108 percent increase to $276.5 billion)Preventative and personalized health (78 percent increase to $243 billion)Complementary and alternative medicine (65 percent increase to $113 billion)
 

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein is the Founder & CEO of The Goldstein Group. During her 25-year career, executives in the CPG and Pharmaceutical industries have turned to Terri for her expertise in brand identity and design. Terri has strengthened the brand identity and business health of over 400 global and domestic consumer products and services developing iconic brand identities that truly endure the test of time. 
 

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein

Founder & CEO
The Goldstein Group

Terri Goldstein is the Founder & CEO of The Goldstein Group. During her 25-year career, executives in the CPG and Pharmaceutical industries have turned to Terri for her expertise in brand identity and design. Terri has strengthened the brand identity and business health of over 400 global and domestic consumer products and services developing iconic brand identities that truly endure the test of time. 
 
Terri has been profiled in Advertising Age (Packaging Guru Proves What’s On Outside Counts – And Sells) and was named a GDUSA Person to Watch. She is a keynote speaker at PIMS, The Marketing Institute, CHPA and many industry conferences. She serves as a guest lecturer at FIT, regularly contributes to Adweek, Brand Packaging and Graphic Design USA, and is the author of breakthrough research on consumer behavior, recall, and sensory motivation in the retail environment. 

 

Ed Rowland

Founder and Managing Partner
Rowland Global

Ed Rowland

Founder and Managing Partner
Rowland Global

Ed Rowland

Founder and Managing Partner
Rowland Global
 

Seb Mullin

Managing Director
Rude Health

Seb Mullin

Managing Director
Rude Health

Seb Mullin

Managing Director
Rude Health
 

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

19+ years in Healthcare – Pharmaceutical and Consumer (OTC / FMCG) 

Physicist driven by innovation to generate commercial value (backed by intellectual property where possible), using consumer insights for new product development and investigating new technologies for unmet consumer health needs.

Current Categories of interest:
Analgesics, Allergy, Cough and Cold, Dermatology, GI, Nutritionals, Sun Care and Foot Care 

Experience in building teams with multidisciplinary skills, both in UK and US and working with 3rd parties.

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

Coulton Legge

Director Global Open Innovation
Bayer Consumer HealthCare

19+ years in Healthcare – Pharmaceutical and Consumer (OTC / FMCG) 

Physicist driven by innovation to generate commercial value (backed by intellectual property where possible), using consumer insights for new product development and investigating new technologies for unmet consumer health needs.

Current Categories of interest:
Analgesics, Allergy, Cough and Cold, Dermatology, GI, Nutritionals, Sun Care and Foot Care 

Experience in building teams with multidisciplinary skills, both in UK and US and working with 3rd parties.

 

Rajesh Mishra

Vice President, R&D Consumer OTC and Head of OTC R&D
Johnson & Johnson

Rajesh (Raj) Mishra M.D., PhD, currently serves as Vice President R&D Consumer OTC and Head of OTC R&D for the EMEA region based out of the UK. Raj has a wealth of U.S. and global industry experience with broad experience in OTC medicines across multiple therapeutic categories. Raj joined Johnson & Johnson Family of Consumer Companies as Vice President Medical and Clinical Affairs, Global OTC in March, 2014. In this role Raj served on the McNeil Management Board, and also on the Global OTC leadership team.

Rajesh Mishra

Vice President, R&D Consumer OTC and Head of OTC R&D
Johnson & Johnson

Rajesh Mishra

Vice President, R&D Consumer OTC and Head of OTC R&D
Johnson & Johnson

Rajesh (Raj) Mishra M.D., PhD, currently serves as Vice President R&D Consumer OTC and Head of OTC R&D for the EMEA region based out of the UK. Raj has a wealth of U.S. and global industry experience with broad experience in OTC medicines across multiple therapeutic categories. Raj joined Johnson & Johnson Family of Consumer Companies as Vice President Medical and Clinical Affairs, Global OTC in March, 2014. In this role Raj served on the McNeil Management Board, and also on the Global OTC leadership team. Raj was responsible for providing medical and clinical oversight across the entire range of OTC therapeutic areas including pain, upper respiratory/allergy, digestive health, smoking cessation, and RX to OTC switch.

Prior to his current role at Johnson & Johnson, Raj was Vice President and Global Head Medical Affairs & Clinical Research at Merck Consumer Care. At Merck, Raj led the Global Medical and Consumer Science Innovation Center of Excellence, and had responsibility for Medical Affairs, Clinical Operations and the Consumer Science Research Center, providing strategic direction, operational, medical/clinical leadership and management for multiple franchises. Before joining Merck, Raj spent 5+ years in various roles within Medical Affairs and R&D product development at GlaxoSmithKline serving as Vice President R&D for Weight Control and Smoking Cessation and Head of Medical Affairs North America.

Raj earned his Doctor of Medicine (MD) and Masters in General Surgery (MS) at B.J. Medical College, Pune University in India. Raj also holds a Doctor of Philosophy (PhD) In Pharmacology from Southern Illinois University Carbondale School of Medicine and an Advanced Management Program Certification from Wharton, University of Pennsylvania.

 

Kevin Foley

Vice President, Worldwide Business Development
Pfizer Consumer Healthcare

Kevin Foley

Vice President, Worldwide Business Development
Pfizer Consumer Healthcare

Kevin Foley

Vice President, Worldwide Business Development
Pfizer Consumer Healthcare
 

Inga Deakin

Principal
Touchstone Innovations

Inga is an Associate in the Healthcare Ventures team, specialising in investments across medical devices, therapeutics, diagnostics, and healthcare, including digital health. She is currently a Director at Puridify and Ieso Digital Health and a board observer at Veryan Medical and Precision Ocular Devices.

Inga Deakin

Principal
Touchstone Innovations

Inga Deakin

Principal
Touchstone Innovations

Inga is an Associate in the Healthcare Ventures team, specialising in investments across medical devices, therapeutics, diagnostics, and healthcare, including digital health. She is currently a Director at Puridify and Ieso Digital Health and a board observer at Veryan Medical and Precision Ocular Devices.

Previously she worked in business development and technology transfer at the London Bioscience Innovation Centre/Royal Veterinary College in London, commercializing research, sourcing and building industry collaborations. She completed a DPhil and MSc in Neuroscience from the University of Oxford, sponsored by the Wellcome Trust, developing translational models of disease using a range of molecular biology, genetics, electrophysiology, imaging and behavioural techniques. Her first degree was Natural Sciences from the University of Cambridge